UMC Posters

In focus / 23 October 2018

We publish and distribute a variety of well researched, informational posters for conferences and communications.


Here is a selection of some of our best posters. You are free to download, print and share them, but please credit the relevant authors and the UMC if you publish or display any of them and we would also appreciate it if you inform us.

Evaluation of a predictive model for suspected drug-drug interactions in routine signal detection by Sara Hult, Tomas Bergvall, Thomas Bradley, Lucie Gattepaille, Birgitta Grundmark, Daniele Sartori, Sara Hedfors Vidlin, G Niklas Norén, Johan Ellenius.

Interaction between rosuvastatin and ticagrelor resulting in rhabdomyolysis by Viola Macolic Sarinic, Lovisa Sandberg, Jenny Hartman, Pia Caduff-Janosa.

Unexpectedly high fatality rate in globally collected spontaneous reports of progressive multifocal leukoencephalopathy with alemtuzumab by Maarten van Eijk, Ola Caster.

Natalizumab and rapidly evolving central nervous system lymphoma in VigiBase by Daniele Sartori, Camilla Westerberg, Birgitta Grundmark.

Do they all agree? – Comparing expert signal assessment by Birgitta Grundmark. Daniele Sartori, Johan Ellenius.

Exploring patient reported information in signal detection within a global database by Sarah Watson, Rebecca Chandler, Henric Taavola, Linda Härmark, Birgitta Grundmark, Alem Zekarias, Kristina Star, Florence van Hunsel.

This poster won the first prize at the 2017 ISoP annual meeting. The production of this poster illustrates a successful collaboration internally between Research and Global Communications, and externally with the Dutch national centre, Lareb.

2+2=5:The future of evidence in a post-truth age of alternative facts by Bruce Hugman

Alexandra Hoegberg @alexhoegberg
Team Manager, Global Communications, UMC

You may also like


Guarding nature: The role of ecopharmacovigilance in preventing pharmaceutical pollution

EcoPV aims to monitor and manage the environmental impact of pharmaceuticals. How may we best support this effort?

In focus / 01 September 2024

Ecopharmacovigilance: Ensuring environmental safety from pharmaceuticals

Pharmacovigilance monitors the safety of the medicines we use, but what about those that get into our environment?

In focus / 15 October 2024

Pharmacovigilance in older adults – New podcast episode

Compared to the general population, older adults are more at risk of experiencing adverse drug reactions. Why is this the case, and what does this mean for pharmacovigilance?

In focus / 29 October 2024